Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
Related Posts
Winter storm disrupts thousands of U.S. flights
The Washington, D.C., area had the bulk of the day’s cancellations from the winter storm.
TikTok asks Supreme Court to block U.S. ban pending appeal
President-elect Donald Trump told reporters “I have a warm spot in my heart for Tiktok.”
Modelo owner Constellation Brands outlook disappoints as tariffs weigh on forecast
Modelo and Corona owner Constellation Brands beat quarterly earnings and revenue estimates, but its outlook took a hit from U.S. tariffs on most of its […]